Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Annapolis Ledger.
Press releases published on May 1, 2025

Ex-Wife of D.C. Sniper Mildred Muhammad Delivers Powerful Closing Keynote at 2025 Victims’ Rights Conference
Award-winning global keynote speaker and domestic abuse survivor, Mildred Muhammad, captivates and inspires over 450 attendees with her transformative journey. BALTIMORE, MD, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- Baltimore, MD – April 9, 2025 …

PropertyRoom.com Awarded Contract with Sourcewell to Provide Online Auction Services for Government Agencies Nationwide
FREDERICK, MD, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- PropertyRoom.com Awarded Contract with Sourcewell to Provide Online Auction Services for Government Agencies Nationwide PropertyRoom.com, the nation’s leading online auction site for …

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results
Dosing cohort 3 of the Phase 1 trial of LNCB74 (B7-H4 ADC) in multiple cancers and plan to initiate backfill cohorts in the second half of 2025 Plan to provide a proof of concept data readout in the first half of 2026 Cash of approximately $55.9 million …

Tenable to Participate in Upcoming Investor Events
COLUMBIA, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Tenable®, the exposure management company, today announced its co-chief executive officers, Steve Vintz and Mark Thurmond, will attend the J.P. Morgan Annual Global Technology, Media and Communications …

Altimmune to Present at Upcoming EASL International Liver Congress™ 2025
GAITHERSBURG, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced that the …

Gain Therapeutics to Participate at The Citizens Life Sciences Conference
BETHESDA, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …